Abstract

Therapeutic drugs for cognitive and psychiatric disorders are often characterized by their molecular mechanism of action. Here we demonstrate a new approach to elucidate drug action on large-scale neuronal activity by tracking somatic calcium dynamics in hundreds of CA1 hippocampal neurons of pharmacologically manipulated behaving mice. We used an adeno-associated viral vector to express the calcium sensor GCaMP3 in CA1 pyramidal cells under control of the CaMKII promoter and a miniaturized microscope to observe cellular dynamics. We visualized these dynamics with and without a systemic administration of Zolpidem, a GABAA agonist that is the most commonly prescribed drug for the treatment of insomnia in the United States. Despite growing concerns about the potential adverse effects of Zolpidem on memory and cognition, it remained unclear whether Zolpidem alters neuronal activity in the hippocampus, a brain area critical for cognition and memory. Zolpidem, when delivered at a dose known to induce and prolong sleep, strongly suppressed CA1 calcium signaling. The rate of calcium transients after Zolpidem administration was significantly lower compared to vehicle treatment. To factor out the contribution of changes in locomotor or physiological conditions following Zolpidem treatment, we compared the cellular activity across comparable epochs matched by locomotor and physiological assessments. This analysis revealed significantly depressive effects of Zolpidem regardless of the animal’s state. Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem with the majority (∼65%) significantly decreasing the rate of calcium transients, and a small subset (3%) showing an unexpected and significant increase. By linking molecular mechanisms with the dynamics of neural circuitry and behavioral states, this approach has the potential to contribute substantially to the development of new therapeutics for the treatment of CNS disorders.

Highlights

  • Understanding how drugs affect complex neuronal networks is critical for the future of neuroscience drug discovery

  • Imaging procedure did not disrupt the sleep-promoting effects of Zolpidem To assess whether the imaging surgical preparations and imaging procedures disrupted the sleep-promoting effects of Zolpidem, we conducted a study to compare the effects of Zolpidem in a group of animals in which we conducted telemetry (EEG/EMG and locomotor activity) recordings only (‘‘Telemetry only’’) to another group in which telemetry was conducted at the same time as calcium imaging (‘‘Telemetry+Imaging’’)

  • Visualizing neuronal activity with high resolution has until now been extremely challenging in freely behaving animals

Read more

Summary

Introduction

Understanding how drugs affect complex neuronal networks is critical for the future of neuroscience drug discovery. One of the highlighted techniques is calcium imaging of neuronal activity, in behaving animals [1,2,3]. Imaging neuronal calcium dynamics in behaving animals with miniaturized integrated fluorescent microscopes takes advantage of several recent break-throughs in technology: using viral vectors to express fluorescent indicators in a targeted genetically identified neuronal population [4]; the use of micro-optics to visualize deep brain structures; and utilization of semiconductor optoelectronics for rapid image acquisition [5,6]. Using a miniaturized (,2g) integrated fluorescent microscope (nVista, Palo Alto, CA) allows for high-speed imaging at the cellular level of hundreds of neurons in multiple brain regions, including evolutionally conserved deep structures, in freely behaving rodents [5,6,7]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.